* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : allergy and immunology;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/jakavi-5-mg-comprime
2025
false
false
false
France
French
insurance, health, reimbursement
ruxolitinib phosphate
ruxolitinib
administration, oral
graft vs host disease
Steroid Refractory Graft Versus Host Disease
acute disease
chronic disease
pharmaceutical solutions
child
guidelines for drug use
summary of product characteristics
package leaflet
tablets

---
https://ansm.sante.fr/tableau-acces-derogatoire/m-m-rvaxpro-priorix
2025
false
false
false
France
French
vaccination
infant
drug information
measles-mumps-rubella vaccine
Post-Exposure prophylaxis
measles
continuity of patient care
technical report

---
https://ansm.sante.fr/tableau-acces-derogatoire/velcade-1-mg-poudre-pour-solution-injectable
2025
false
false
false
France
French
drug information
Bortezomib
injections, intravenous
Immunoglobulin Light-chain Amyloidosis
Non-amyloid monoclonal immunoglobulin deposition disease

---
https://ansm.sante.fr/tableau-acces-derogatoire/xalkori
2025
false
false
false
France
French
drug information
administration, oral
Crizotinib
antineoplastic agents
protein kinase inhibitors
capsules
pharmaceutical solutions
child
infant
lymphoma, large-cell, anaplastic
Childhood Anaplastic Large Cell Lymphoma, ALK-Positive
crizotinib
MET Exon 14 Mutation
Locally Advanced Lung Non-Small Cell Carcinoma
adult
Metastatic Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
continuity of patient care

---
https://ansm.sante.fr/tableau-marr/cladribine
2025
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests

---
https://ansm.sante.fr/tableau-acces-derogatoire/teclistamab
2025
false
false
false
France
French
drug information
Teclistamab
adult
multiple myeloma
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
summary of product characteristics
package leaflet
antibodies, monoclonal
Antineoplastic Agents, Immunological
teclistamab

---
https://ansm.sante.fr/tableau-acces-derogatoire/enhertu-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
Metastatic Gastric Adenocarcinoma
stomach neoplasms
adenocarcinoma
neoplasm metastasis
Locally Advanced Gastric Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Locally Advanced Gastroesophageal Junction Adenocarcinoma
HER2/Neu Positive
trastuzumab deruxtecan
infusions, intravenous
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
Metastatic HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
HER2-Low Breast Carcinoma
Metastatic HER2-Low Breast Carcinoma
neoplasm recurrence, local

---
https://ansm.sante.fr/tableau-acces-derogatoire/thalidomide-bms-50-mg-gelule
2025
false
false
false
France
French
guidelines for drug use
continuity of patient care
thalidomide
administration, oral
Jessner lymphocytic infiltration of the skin
lupus erythematosus, cutaneous
stomatitis, aphthous
Immune complex reaction co-occurrent and due to multibacillary leprosy (disorder)
crohn disease
erythema multiforme
Erythema multiforme major
technical report

---
https://www.ema.europa.eu/en/medicines/human/EPAR/rybrevant
2025
false
false
false
Netherlands
French
English
amivantamab
amivantamab
amivantamab
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
rybrevant
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
adult
aged
carcinoma, non-small-cell lung
bronchial neoplasms
Activating EGFR Exon 20 Mutation
carcinoma, non-small-cell lung
bronchial neoplasms
Gain of Function Mutation
genes, erbb-1
Refractory Lung Non-Small Cell Carcinoma
infusions, intravenous
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
Non-small cell lung cancer with mutation in epidermal growth factor receptor (disorder)
advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
EGFR Exon 19 Deletion Mutation
EGFR NP_005219.2:p.L858R

---
https://ansm.sante.fr/tableau-marr/adrenaline-3
2025
false
false
false
France
French
risk management
epinephrine
guidelines for drug use
self administration
injections, intramuscular
epinephrine
anaphylaxis
patients guideline
drug storage
video recording
epinephrine

---
https://ansm.sante.fr/tableau-marr/fingolimod
2025
false
false
false
France
French
guidelines for drug use
patient education handout
Fingolimod Hydrochloride
pregnancy
administration, oral
immunosuppressive agents
immunosuppressive agents
fingolimod
continuity of patient care
Fingolimod Hydrochloride
teratogens
multiple sclerosis, relapsing-remitting
breast feeding
Fingolimod Hydrochloride
risk management

---
https://publications.msss.gouv.qc.ca/msss/document-002830/
2025
false
false
false
Canada
coronavirus infections
pneumonia, viral
scientific and technical information
Examination Questions
social networks
social support
Vaccins
vaccination
preventive immunization/medication
social work
intention
social networking
vaccination
health services
mass vaccination
vaccination, nos
Vaccinia
community networks
health personnel
vaccination
health services
pandemics
viral vaccines
COVID-19
COVID-19 Vaccines

---
http://publications.msss.gouv.qc.ca/msss/document-001243/
2025
false
false
false
false
Canada
French
scientific and technical information
vaccination
papillomavirus vaccines
papillomavirus infections
safety management
immunization programs
quebec
immunization schedule
homosexuality, male

---
https://ansm.sante.fr/tableau-marr/pomalidomide
2025
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://www.has-sante.fr/jcms/p_3576262/fr/jakavi-ruxolitinib-maladie-du-greffon-pediatrie
2025
false
false
false
France
administration, oral
pharmaceutical solutions
graft vs host disease
child
ruxolitinib
Janus Kinase Inhibitors
evaluation of the transparency committee
ruxolitinib

---
https://www.academie-medecine.fr/vacciner-les-seniors-un-devoir-de-prevention-neglige/
2025
France
scientific and technical information
aged
vaccination, nos
vaccinia, nos
vaccination
vaccines
vaccinia
preventive immunization/medication
vaccination
vaccine, nos

---
https://www.cochrane.org/fr/CD013476/CENTRALED_une-procedure-visant-induire-une-tolerance-laspirine-est-elle-un-traitement-efficace-pour-les
2025
United Kingdom
review of literature
french abstract
adulthood
methods
adult
aspirin
hypersensitivity
acetylsalicylic acid
due to
procedures
non-steroidal anti-inflammatory agent, nos
procedure, nos
anti-inflammatory agents, non-steroidal
tolerance, nos

---
https://www.has-sante.fr/jcms/p_3578223/fr/therapie-digital-joe
2025
France
health technology assessment
asthma
Pediatricians
pediatrics
pediatrician
asthma
asthma, nos
therapy, nos
digitalis, nos
digitalis
digitalis glycosides

---
https://www.cochrane.org/fr/CD012532/CENTRALED_quels-sont-les-benefices-et-les-risques-des-differents-medicaments-dimmunotherapie-pour-traiter-le
2025
United Kingdom
review of literature
french abstract
drug therapy
risk assessment
brain neoplasms
drug, nos
immunotherapy
risks and benefits
immunotherapy, nos
glioblastoma
glioblastoma, nos

---
https://www.has-sante.fr/jcms/p_3578223/fr/therapie-digitale-joe
2025
France
health technology assessment
asthma, nos
digitalis, nos
asthma
therapy, nos
Pediatricians
asthma
digitalis
pediatrician
pediatrics

---
https://www.inspq.qc.ca/publications/3610
2025
Canada
technical report
quebec
organization and administration
Transfusion Reaction

---
https://www.santepubliquefrance.fr/presse/2025/asthme-accident-vasculaire-cerebral-diabete-quels-impacts-de-la-pollution-de-l-air-ambiant-sur-la-sante-et-quel-impact-economique
2025
France
popular works
cost savings
air pollution, indoor
cerebrovascular accident, nos
economics
health
asthma
air pollution
asthma
air pollution
diabetes mellitus
stroke
Embolic Stroke
stroke/cerebrovascular accident
asthma, nos

---
https://www.santepubliquefrance.fr/content/download/694367/4560433?version=1
2025
France
scientific and technical information
cerebrovascular accident, nos
asthma
stroke
air pollution, indoor
asthma
stroke/cerebrovascular accident
health
air pollution
air pollution
diabetes mellitus
asthma, nos
economics
cost savings
Embolic Stroke

---
https://ansm.sante.fr/actualites/vaccins-contre-le-covid-19-les-rapports-denquete-confirment-de-nouveau-leur-profil-de-securite
2025
false
false
false
France
French
COVID-19 Vaccines
product surveillance, postmarketing
health surveys
drug information
COVID-19 Vaccines
vaccination
COVID-19
pregnancy
breast feeding
Covid-19 vaccines
adverse drug reaction reporting systems
france

---
https://www.has-sante.fr/jcms/p_3590117/fr/vaccin-antigrippal-vaxigrip-transition-du-vaccin-antigrippal-vaxigrip-de-sa-forme-quadrivalente-a-une-forme-trivalente-dans-la-strategie-de-vaccination-contre-la-grippe-saisonniere
2025
France
public health guidelines
influenza vaccination
health planning guidelines
vaxigrip
vaccinia virus vaccine
influenza
influenza, human
influenza virus vaccine
influenza vaccines
vaccination
vaccination
preventive immunization/medication
due to
vaxigrip
influenza A virus

---
https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/drees-methodes/250227_DM_appariement-EIR-EIC-Eniacrams
2025
France
technical report
matched-pair analysis
socialism
complement system proteins
mild
retirement
retirement, nos

---
https://ansm.sante.fr/tableau-acces-derogatoire/elahere
2025
false
false
false
France
French
insurance, health, reimbursement
mirvetuximab soravtansine
mirvetuximab soravtansine
drug information
immunoconjugates
antibodies, monoclonal, humanized
maytansine
Antineoplastic Agents, Immunological
Folate Receptor Alpha Positive
ovarian neoplasms
peritoneal neoplasms
fallopian tube neoplasms

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_2025_07_territorialise_iim_b_rennes.pdf
2025
France
scientific and technical information
cluster analysis
mass vaccination
vaccination
preventive immunization/medication
vaccination
infectious disease, nos
meningococcus vaccination
meningococcal infections

---
https://www.has-sante.fr/jcms/p_3593981/fr/epidemie-de-chikungunya-utilisation-du-vaccin-ixchiq-a-la-reunion-et-a-mayotte
2025
France
public health guidelines
vaccines
Chikungunya Fever
disease outbreaks
Off-Label use
vaccination
vaccination
group processes
preventive immunization/medication
vaccine, nos
comoros
vaccinia
mayotte
epidemics

---
https://www.has-sante.fr/jcms/p_3594381/fr/rystiggo-rozanolixizumab-myasthenie
2025
false
false
false
France
drug therapy, combination
adult
treatment outcome
insurance, health, reimbursement
immunosuppressive agents
rozanolixizumab
generalised myasthenia gravis with anti-acetylcholine receptor antibody
Adult-onset myasthenia gravis
infusions, subcutaneous
evaluation of the transparency committee
myasthenia gravis
rozanolixizumab

---
https://www.has-sante.fr/jcms/p_3593724/fr/avis-n2025-0010/ac/sespev-du-27-fevrier-2025-du-college-de-la-haute-autorite-de-sante-relatif-a-la-pertinence-de-realiser-une-campagne-de-vaccination-contre-la-covid-19-au-printemps-2025
2025
false
false
false
France
public health guidelines
mass vaccination
COVID-19 Vaccines

---
https://www.has-sante.fr/jcms/p_3592810/fr/cuvitru-immunoglobuline-humaine-normale-immunoglobuline
2025
false
false
false
France
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
immunoglobulins, normal human, for extravascular adm.
immunologic factors
adult
child
adolescent
immunologic deficiency syndromes
Secondary immune deficiency disorder (disorder)
Primary Immunodeficiency Diseases
evaluation of the transparency committee
immunoglobulins

---
https://www.has-sante.fr/jcms/p_3594402/fr/hyqvia-immunoglobuline-humaine-normale-plasmatique-polyradiculonevrite-inflammatoire-demyelinisante-chronique-pidc
2025
false
false
false
France
infusions, subcutaneous
treatment outcome
insurance, health, reimbursement
immunoglobulins, normal human, for extravascular adm.
adult
adolescent
child
immunologic factors
infant, newborn
infant
evaluation of the transparency committee
polyradiculoneuropathy, chronic inflammatory demyelinating
immunoglobulins

---
https://www.has-sante.fr/jcms/p_3594375/fr/tepadina-thiotepa-greffe
2025
false
false
false
France
Product containing only thiotepa in parenteral dose form (medicinal product form)
infusions, intravenous
treatment outcome
insurance, health, reimbursement
transplantation conditioning
transplantation, autologous
transplantation, homologous
intense chemotherapy program
evaluation of the transparency committee
thiotepa
hematopoietic stem cell transplantation

---
https://www.has-sante.fr/jcms/p_3594723/fr/influvac-vaccin-grippal-inactive-a-antigenes-de-surface-vaccin-antigrippal
2025
false
false
false
France
INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B
INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2)
INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1)
Trivalent Influenza Vaccine
evaluation of the transparency committee
influenza vaccines
preventive immunization/medication
hepatitis surface antigen
influenza virus vaccine
vaccines, inactivated
antigens, surface
vaccination

---
https://ansm.sante.fr/tableau-marr/isatuximab
2025
false
false
false
France
French
risk management
isatuximab
guideline
patient education handout
blood transfusion
indirect coombs test
Laboratory test interference

---
https://www.has-sante.fr/jcms/p_3594961/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg-chez-l-adulte-et-l-adolescent
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
spesolimab
Generalized pustular psoriasis
Generalized pustular psoriasis flare
evaluation of the transparency committee
adolescent
spesolimab
adult
psoriasis

---
https://www.has-sante.fr/jcms/p_3594958/fr/vaxigrip-vaccin-grippal-trivalent-inactive-a-virion-fragmente-vaccin-antigrippal
2025
France
evaluation of the transparency committee
vaccination
vaxigrip
preventive immunization/medication
fragmentation, nos
influenza virus vaccine
virion
influenza vaccines
vaccines, inactivated
vaxigrip

---
https://www.infectiologie.com/UserFiles/File/grand-public/mmif/fiche-patient-mmif-25-vaccin-grossesse.pdf
2025
France
patient education handout
vaccination, nos
vaccination
pregnancy
vaccine, nos
vaccinia, nos
vaccinia
preventive immunization/medication
vaccination
pregnancy, nos
vaccines

---
https://www.has-sante.fr/jcms/p_3598458/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2-faible-ou-ultra-faible
2025
false
false
false
France
evaluation of the transparency committee
breast neoplasms
Trastuzumab
trastuzumab deruxtecan
trastuzumab

---
https://www.has-sante.fr/jcms/p_3598812/fr/nordimet-methotrexate-psoriasis-en-plaque-modere
2025
false
false
false
France
adult
insurance, health, reimbursement
treatment outcome
injections, subcutaneous
methotrexate
evaluation of the transparency committee
psoriasis
methotrexate

---
https://publications.msss.gouv.qc.ca/msss/document-003875/
2025
Canada
handbooks
hypersensitivity
tool, nos
therapy, nos

---
Siiltibcy - Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10)
https://www.ema.europa.eu/en/medicines/human/EPAR/siiltibcy
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
rdESAT-6
rCFP-10
Mycobacterium tuberculosis, antigen ESAT6, fused with Mycobacterium tuberculosis, antigen CFP10
ESAT-6 protein, mycobacterium tuberculosis
CFP-10 protein, mycobacterium tuberculosis
bacterial proteins
recombinant proteins
antigens, bacterial
mycobacterium tuberculosis
tuberculosis
infant
child
adolescent
adult
drug approval
europe
injections, intradermal
skin tests
drug evaluation, preclinical

---
Ixchiq - Chikungunya vaccine (live)
https://www.ema.europa.eu/en/medicines/human/EPAR/ixchiq
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
vaccine potency
Immunogenicity, Vaccine
Chikungunya vaccine (live)
Chikungunya Fever
vaccination
Chikungunya virus, strain delta5nsP3, live attenuated
chikungunya virus
injections, intramuscular
viral vaccines
risk management
product surveillance, postmarketing
adolescent
adult
drug approval
europe
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/wezenla
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
Ustekinumab
Ustekinumab
biosimilar pharmaceuticals

---
Flucelvax - influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
https://www.ema.europa.eu/en/medicines/human/EPAR/flucelvax
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
antigens, surface
influenza, human
influenza vaccines
vaccines, inactivated
Antigen of Influenza virus surface protein (substance)

---
Fluenz - influenza vaccine (live attenuated, nasal)
https://www.ema.europa.eu/en/medicines/human/EPAR/fluenz
2025
false
false
false
France
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
influenza, human
influenza vaccines
vaccination
Trivalent Live-Attenuated Influenza Vaccine

---
https://www.has-sante.fr/jcms/p_3600181/fr/ixchiq-vaccin-contre-le-chikungunya-vivant-attenue-chikungunya
2025
false
false
false
France
vaccination
Chikungunya vaccine (live)
insurance, health, reimbursement
vaccine potency
adult
evaluation of the transparency committee
vaccines, attenuated
Chikungunya Fever
vaccination

---
https://www.has-sante.fr/jcms/p_3600306/fr/fluenz-vaccin-grippal-trivalent-vivant-attenue-nasal-vaccin-antigrippal
2025
France
evaluation of the transparency committee
influenza vaccines
vaccination
vaccines, attenuated
preventive immunization/medication
attenuated by
nose, nos
influenza virus vaccine

---
https://www.has-sante.fr/jcms/p_3601437/fr/beovu-brolucizumab-degenerescence-maculaire-liee-a-l-age-dmla-oedeme-maculaire-diabetique-omd
2025
France
evaluation of the transparency committee
macular degeneration
degeneration, nos
brolucizumab
diabetes mellitus
age, nos
macular degeneration
macule, nos
brolucizumab
macular edema
edema, nos

---
https://www.has-sante.fr/jcms/p_3601303/fr/edurant-rilpivirine-vih
2025
false
false
false
France
child
adult
evaluation of the transparency committee
human immunodeficiency virus, nos
Rilpivirine
hiv infections

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/prevention-dune-reaction-dhypersensibilite-aux-agents-de-contraste.html
2025
Canada
technical report
hypersensitivity
hypersensitivity reaction, nos
contrast media

---
https://ansm.sante.fr/actualites/lansm-accompagne-la-campagne-vaccinale-contre-le-chikungunya-vaccin-ixchiq
2025
false
false
false
France
French
drug information
vaccination
Chikungunya Fever
Chikungunya vaccine (live)
reunion
patient education handout
product surveillance, postmarketing
viral vaccines

---
https://www.ethique-cancer.fr/avis/avis-ndeg-43
2025
France
public health guidelines
immunoglobulins
immunoglobulin, nos
face
changing
principle-based ethics
policy
gift giving
plasma

---
https://www.cfp.ca/content/71/4/e66
2025
Canada
journal article
hypersensitivity
uncertainty
penicillin
penicillins
allergy to penicillin

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_no2025_11_vaccination_ixchiq_dont_voyageurs_vf.pdf
2025
France
scientific and technical information
vaccination
vaccine, nos
vaccines
indicators and reagents
vaccinia
preventive immunization/medication
indication of
vaccination
Chikungunya Fever
vaccinia virus vaccine
suggestive of
homing behavior

---
https://www.has-sante.fr/jcms/p_3603354/fr/fampyra-fampridine-sclerose-en-plaques-sep
2025
false
false
false
France
evaluation of the transparency committee
multiple sclerosis
multiple sclerosis
4-Aminopyridine
fampridine
multiple sclerosis, nos

---
https://sante.gouv.fr/actualites/presse/communiques-de-presse/article/les-autorites-sanitaires-retirent-les-personnes-de-65-ans-et-plus-des-cibles-de
2025
false
false
false
France
French
pharmacovigilance note
Chikungunya Fever
vaccination
vaccines, attenuated
Chikungunya vaccine (live)
aged
reunion
mayotte
Chikungunya virus, strain delta5nsP3, live attenuated

---
https://www.cochrane.org/fr/CD015551/CENTRALED_quels-sont-les-benefices-et-risques-des-vaccins-pour-la-prevention-des-maladies-infectieuses-chez
2025
United Kingdom
review of literature
french abstract
vaccinia, nos
infection control
disease
communicable diseases
vaccine, nos
cancer
vaccination, nos
preventive immunization/medication
infectious disease, nos
vaccines
risks and benefits
adult disease, nos
neoplasm, malignant
vaccination
infectious diseases
risk assessment
adult
neoplasms

---
https://www.has-sante.fr/jcms/p_3605182/fr/prevenar-20-vaccin-pneumococcique-polyosidique-conjugue-20-valent-adsorbe-ou-vpc20-infections-a-pneumocoques
2025
false
false
false
France
evaluation of the transparency committee
preventive immunization/medication
vaccination
pneumococcal infections
prevenar
pneumococcal infectious disease, nos
polysaccharides
pneumococcal polysaccharide vaccine
pneumococcal vaccination
pneumococcal vaccines
vaccines, conjugate

---
https://www.has-sante.fr/jcms/p_3604202/fr/rybrevant-amivantamab-cancer-bronchique-non-a-petites-cellules-exon-19-exon-21
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
amivantamab
Non-small cell lung cancer with mutation in epidermal growth factor receptor (disorder)
bronchial neoplasms
infusions, intravenous
Antineoplastic Agents, Immunological
antibodies, bispecific
Amivantamab/Carboplatin/Pemetrexed Regimen
antineoplastic combined chemotherapy protocols
carboplatin
Pemetrexed
adult
EGFR NP_005219.2:p.L858R
EGFR Exon 19 Deletion Mutation
evaluation of the transparency committee
amivantamab
bronchial neoplasms

---
https://www.has-sante.fr/jcms/p_3605173/fr/zutectra-immunoglobuline-humaine-de-l-hepatite-b-prevention-de-la-reactivation-de-l-hepatite-b
2025
false
false
false
France
BT088 immunoglobulin, human
Reactivation of hepatitis B viral hepatitis (disorder)
hepatitis b immunoglobulin
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
adult
liver transplantation
Entire transplanted liver (body structure)
Hepatitis B Virus Surface Antigen Negative
Hepatitis B DNA assay negative
hepatitis B
evaluation of the transparency committee
hepatitis B
immunoglobulins
hepatitis B hyperimmune globulin

---
https://sfsep.org/wp-content/uploads/2025/05/SFSEP_Recommandation_Infections_vaccinations_et_NMOSD_MOGAD_de_l-adulte.pdf
2025
France
scientific and technical information
vaccinia
vaccines
preventive immunization/medication
vaccine, nos
vaccination
vaccination
vaccinia, nos
infectious disease, nos
neuromyelitis optica
adult
Infections
vaccination, nos
adulthood

---
https://www.has-sante.fr/jcms/p_3606853/fr/efluelda-vaccin-antigrippal-trivalent-inactive-a-virion-fragmente-60-g-ha/souche-vaccin-antigrippal
2025
France
evaluation of the transparency committee
Trivalent Influenza Vaccine
vaccines, inactivated
preventive immunization/medication
influenza vaccines
virion
influenza virus vaccine
fragmentation, nos
vaccination

---
https://www.has-sante.fr/jcms/p_3606844/fr/fluad-vaccin-trivalent-antigrippal-antigenes-de-surface-inactive-avec-adjuvant-vaccin-antigrippal
2025
France
evaluation of the transparency committee
influenza vaccines
adjuvant, nos
preventive immunization/medication
vaccination
hepatitis surface antigen
Trivalent Influenza Vaccine
antigens, surface
influenza virus vaccine

---
https://www.immunite-cancer.fr/
false
false
false
false
false
France
periodicals
immunity
immunotherapy
medical oncology
neoplasms

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-immunoglobulines.html
2025
false
false
false
false
false
Canada
guideline
technical report
immunoglobulins

---
https://www.has-sante.fr/jcms/p_3576429/fr/trumenba-vaccin-meningococcique-groupe-b-recombinant-adsorbe-vaccin-anti-meningococcique-serogroupe-b
2025
false
false
false
France
Meningococcal group B vaccine (product)
evaluation of the transparency committee
vaccines, recombinant
vaccination
Serogroup
preventive immunization/medication
neisseria meningitidis
meningococcal vaccines
vaccines, synthetic
vaccine, nos
population groups

---
https://www.has-sante.fr/jcms/p_3577021/fr/vabysmo-faricimab-oedeme-maculaire-secondaire-a-une-occlusion-de-branche-veineuse-retinienne-obvr-ou-de-la-veine-centrale-de-la-retine-ovcr
2025
false
false
false
France
faricimab
vision disorders
Central Retinal Vein Occlusion
intravitreal injections
adult
evaluation of the transparency committee
macular edema
faricimab
retinal vein occlusion
Branch Vein Occlusion

---
https://www.has-sante.fr/jcms/p_3576495/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
Generalized pustular psoriasis
Generalized pustular psoriasis flare
spesolimab
adult
adolescent
evaluation of the transparency committee
psoriasis
spesolimab

---
https://www.has-sante.fr/jcms/p_3574072/fr/transition-du-vaccin-antigrippal-fluenz-de-sa-forme-quadrivalente-a-une-forme-trivalente-dans-la-strategie-de-vaccination-contre-la-grippe-saisonniere
2025
France
public health guidelines
preventive immunization/medication
due to
influenza vaccination
vaccination
health planning guidelines
influenza, human
influenza vaccines
influenza
influenza virus vaccine
vaccination

---
https://www.has-sante.fr/jcms/p_3577030/fr/benlysta-belimumab-lupus-systemique-actif
2025
false
false
false
France
belimumab
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
belimumab

---
https://www.has-sante.fr/jcms/p_3574253/fr/ventoline-salbutamol-asthme
2025
false
false
false
France
injections, subcutaneous
acute disease
evaluation of the transparency committee
albuterol
asthma

---
https://ansm.sante.fr/actualites/rifampicine-conduites-a-tenir-dans-un-contexte-de-fortes-tensions-dapprovisionnement
2025
false
false
false
France
French
rifampin
france
administration, oral
infusions, intravenous
guidelines for drug use
antibiotics, antitubercular
-
-
-
osteoarticular infections
tuberculosis
Infection associated with device (disorder)
Infection associated with vascular device (disorder)
Staphylococcal endocarditis (disorder)

---
https://ansm.sante.fr/tableau-marr/zilucoplan
2025
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
injections, subcutaneous
zilucoplan
Drug-Related side effects and adverse reactions
zilucoplan
complement inactivating agents
vaccination
meningococcal infections
meningococcal vaccines
guideline

---
https://ansm.sante.fr/tableau-marr/adrenaline
2025
false
false
false
France
French
risk management
guidelines for drug use
epinephrine
epinephrine
Self injection
self administration
patient education handout
video recording

---
https://ansm.sante.fr/tableau-acces-derogatoire/rybrevant
2025
false
false
false
France
French
summary of product characteristics
amivantamab
Antineoplastic Agents, Immunological
amivantamab
advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
carcinoma, non-small-cell lung
guidelines for drug use
package leaflet
EGFR Exon 19 Deletion Mutation
EGFR NP_005219.2:p.L858R
EGFR Exon 20 Insertion Mutation

---
https://ansm.sante.fr/tableau-acces-derogatoire/tedopi
2025
false
false
false
France
French
drug information
insurance, health, reimbursement
injections, subcutaneous
cancer vaccines
Multi-neo-epitope Vaccine OSE 2101

---
https://ansm.sante.fr/tableau-marr/romiplostim
2024
false
false
false
France
French
injections, subcutaneous
romiplostim
risk management
romiplostim
guidelines for drug use
child
adult
patients guideline
clinical tool
home nursing
drug dosage calculations
self administration
receptors, fc
recombinant fusion proteins
thrombopoietin

---
https://publications.msss.gouv.qc.ca/msss/document-002140/
2024
false
false
false
Canada
popular works
immunization
quebec
influenza, nos
health
health personnel
Program
Examination Questions
Intertrochanteric fracture
vaccination, nos
immunization programs
intention
influenza, human
immunization
health

---
https://publications.msss.gouv.qc.ca/msss/document-002648/
2024
false
false
false
Canada
quebec
Invasive Streptococcus pneumoniae disease (disorder)
immunization schedule
infant
10-valent pneumococcal vaccine
13-valent pneumococcal vaccine
Asplenia
hemoglobinopathies
hematopoietic stem cell transplantation
scientific and technical information
pneumococcal infections
vaccination
child
immunization programs
adult
pneumococcal vaccines
vaccination
pneumococcal vaccines

---
http://publications.msss.gouv.qc.ca/msss/document-001040/
2024
false
true
false
Canada
immunization schedule
vaccines
measles-mumps-rubella vaccine
meningococcal vaccines
pneumococcal vaccines
influenza vaccines
Diphtheria-Tetanus-Pertussis vaccine
rotavirus vaccines
child
infant
popular works
vaccination

---
http://publications.msss.gouv.qc.ca/msss/document-001468/
2024
false
false
false
Canada
French
patient education handout
scientific and technical information
twinrix
hepatitis b vaccination
preventive immunization/medication
intention
viral hepatitis
immunization programs
schools
medial
Examination Questions
hepatitis B vaccines
hepatitis B
Examination Questions
hepatitis B
hepatitis A vaccines
vaccines, combined

---
https://ansm.sante.fr/tableau-acces-derogatoire/yescarta-0-4-2-x-108-cellules-dispersion-pour-perfusion#
2024
false
false
false
France
French
axicabtagene ciloleucel
axicabtagene ciloleucel
biological products
Antineoplastic Agents, Immunological
Recurrent High Grade B-Cell Lymphoma
lymphoma, large B-Cell, diffuse
adult
Refractory High Grade B-Cell Lymphoma
drug information
immunotherapy, adoptive
antigens, CD19

---
https://ansm.sante.fr/tableau-marr/teriflunomide
2024
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines

---
https://ansm.sante.fr/tableau-marr/atezolizumab
2024
false
false
false
France
French
atezolizumab
atezolizumab
atezolizumab
Drug-Related side effects and adverse reactions
risk management
drug information
patient education handout
Drug-Related side effects and adverse reactions
signs and symptoms
antineoplastic agents
antineoplastic agents
immune system diseases
immune system diseases
antibodies, monoclonal
antibodies, monoclonal

---
https://ansm.sante.fr/tableau-marr/emicizumab
2024
false
false
false
France
French
emicizumab
risk management
thromboembolism
hemorrhage
thrombotic microangiopathies
blood coagulation tests
risk
hemorrhage
hemophilia A
patients guideline
guidelines for drug use
handbooks
Drug-Related side effects and adverse reactions
injections, subcutaneous
emicizumab
emicizumab
continuity of patient care
antibodies, bispecific
antibodies, monoclonal, humanized

---
https://ansm.sante.fr/tableau-marr/insuline-degludec
2024
false
false
false
France
French
risk management
insulin degludec
medication errors
guidelines for drug use
injections, subcutaneous
insulin degludec
patient education handout
hypoglycemic agents
guideline
insulin, long-acting

---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide

---
https://ansm.sante.fr/tableau-marr/rituximab
2024
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding

---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet

---
https://www.cochrane.org/fr/CD011381/MS_quels-sont-les-benefices-et-les-risques-des-medicaments-agissant-sur-le-systeme-immunitaire-pour
2024
false
false
false
France
United Kingdom
review of literature
french abstract
Immunomodulators
immunosuppressive agents
multiple sclerosis, nos
Network Meta-Analysis as Topic
immunomodulators
Multiple sclerosis
multiple sclerosis, relapsing-remitting
multiple sclerosis
immunologic factors

---
https://ansm.sante.fr/actualites/nouvelles-donnees-en-faveur-dun-risque-accru-de-saignements-menstruels-abondants-apres-la-primovaccination-contre-le-covid-19
2024
false
false
false
France
French
pharmacovigilance note
COVID-19 Vaccines
vaccination
COVID-19
mRNA Vaccines
Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
technical report
menorrhagia
covid-19, RNA-based vaccine
risk
risk assessment

---
https://www.has-sante.fr/jcms/p_3491589/fr/vivotif-salmonella-enterica-serovar-typhi-souche-ty21a-vaccin-anti-typhoidique-vivant-attenue
2024
false
false
false
France
Ty21a typhoid vaccine
polysaccharides, bacterial
treatment outcome
insurance, health, reimbursement
vaccination
administration, oral
typhoid, oral, live attenuated
typhoid fever
immunization, active
evaluation of the transparency committee
vaccination
salmonella typhi
typhoid-paratyphoid vaccines

---
https://www.santepubliquefrance.fr/presse/2024/impact-de-la-pollution-de-l-air-dans-les-etablissements-scolaires-sur-l-asthme-des-enfants-de-6-a-11-ans-sante-publique-france-presente-les-premi
2024
France
scientific and technical information
CHFR Gene
Impact
Smoking at Diagnosis
schools
Loss of Chromosome 11
Severity of Symptom Score 6
resulting in
Offspring
french
Six
public health
child, nos
Clinical Status Ordinal Scale Outcome 6
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
Child
Air
Thought Score 6
asthma
Illness Intrusiveness Rating 6
Child Health
Autonomic Nervous System
Public Health
Fear Score 6
air pollution
Asthma
air pollution
Asthma Pathway
Eleven
asthma
Established
france
asthma, nos

---
https://publications.msss.gouv.qc.ca/msss/document-003690/
2024
Canada
handbooks
Guide Device
Medical Examination
Radiation Boost
complement system proteins
symptom assessment
Handbook
Digital Mammography
mammography, nos
mammography
CDISC SDTM Medical Evaluator Identifier Terminology

---
https://iris.who.int/handle/10665/375750
2024
Switzerland
journal article
Implementation
Nicotine Lozenge
vaccination
Consultation
vaccination
September
vaccinia virus vaccine
group processes
Reunion
advisory committees
preventive immunization/medication
Meeting
Vaccine Research
vaccines
Vaccination
research

---
https://ansm.sante.fr/tableau-acces-derogatoire/itraconazole
2024
false
false
false
France
French
itraconazole
guidelines for drug use
administration, oral
tinea
child
microsporum
antifungal agents
itraconazole
continuity of patient care

---
https://www.has-sante.fr/jcms/p_3415710/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-comirnaty-bivalent-original/baba-4-5-10-g/dose-dans-la-strategie-de-rappel-des-enfants-de-5-a-11-ans-revolus-a-risque-de-forme-grave
2024
France
public health guidelines
Vaping
Offspring
Severity Four Out of Five
risk
Recollect
child, nos
severe
health planning guidelines
Eleven
COVID-19 Vaccines
Loss of Chromosome 11
vaccination
Callback
Reminder
Per Hundred Thousand
Bivalent Vaccines
Serious Risk
Recommendation
Strategy
Per Ten Thousand
Vaccination
Child
preventive immunization/medication
child
Vaccine
Placement
vaccination
Booster
vaccinia virus vaccine
Autonomic Nervous System

---
https://www.has-sante.fr/jcms/p_3494172/fr/avis-n-2024-001/ac/sespev-du-08-fevrier-2024-du-college-de-la-haute-autorite-de-sante-relatif-a-la-date-de-lancement-de-la-campagne-de-vaccination-au-printemps-2024-contre-la-covid-19
2024
France
scientific and technical information
Date Fruit
health
Vaccination
COVID-19 Infection
Newton
COVID-19
Spring
preventive immunization/medication
COVID-19 Vaccines
vaccination, nos
N Category
MATCH Arm EAY131-N
attitude to health
vaccination
Neither Agree or Disagree
No
N
Relative Value
vaccination
judgment
Regulatory Authority
College Completion
mass vaccination
Spring Device
Nano
February
schools
Signal to Noise Ratio
Tumor to Normal

---
https://ansm.sante.fr/tableau-marr/methotrexate-per-os
2024
false
false
false
France
French
guidelines for drug use
risk management
methotrexate
administration, oral
patient education handout
medication errors

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2024-5-8-fevrier
2024
false
false
false
France
French
pharmacovigilance note
nirmatrelvir and ritonavir drug combination
nirmatrelvir and ritonavir drug combination
immunosuppressive agents
drug therapy, combination
drug interactions

---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout

---
https://www.has-sante.fr/jcms/p_3495394/fr/takhzyro-lanadelumab-angioedeme-hereditaire
2024
false
false
false
France
French
insurance, health, reimbursement
lanadelumab
evaluation of the transparency committee
child
angioedemas, hereditary
Hereditary angioedema attack
lanadelumab
treatment outcome
guidelines for drug use
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)

---
https://www.has-sante.fr/jcms/p_3497032/fr/azelastine-chlorhydrate-/-fluticasone-propionate-eg-chlorhydrate-d-azelastine-/-propionate-de-fluticasone-rhinite-allergique
2024
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
rhinitis, allergic, seasonal
fluticasone, combinations
administration, intranasal
histamine H1 antagonists, non-sedating
anti-inflammatory agents
evaluation of the transparency committee
azelastine hydrochloride
Fluticasone
rhinitis, allergic, perennial
Fluticasone Propionate
azelastine

---
https://www.has-sante.fr/jcms/p_3492882/fr/alvesco-ciclesonide-asthme
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
glucocorticoids
administration, inhalation
ciclesonide
evaluation of the transparency committee
asthma
ciclesonide

---
https://www.cmg.fr/wp-content/uploads/2024/02/Memo-vaccin-25-CMG-2023-actualise-fevrier-2024.pdf
2024
France
scientific and technical information
methacryloxypropyltrimethoxysilane
Autonomic Nervous System
Splayed
vaccination
Vaccination
preventive immunization/medication
vaccines, synthetic
vaccination, nos
Twenty Five
Synthetic Data
dataset

---
https://minerva-ebp.be/FR/Article/2363
2024
Belgium
critical appraisal or critical reading
disease
disease, nos
Illinois
Useful
tretinoin
fatty acids, Omega-3
Autologous Anti-CD19/CD22 CAR T-cells AUTO3
Immune
vitamin D
Disease or Disorder
vitamin d, nos
Interleukin
fatty acid, nos
fatty acids
immune system diseases
What Month is it
Vitamin D Measurement
Ergocalciferol
Israel

---
https://www.has-sante.fr/jcms/p_3473151/fr/fiche-bum-dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2024
false
false
false
France
dupilumab
benralizumab
mepolizumab
tezepelumab
other systemic drugs for obstructive airway diseases
adult
child
drug therapy, combination
Severe persistent asthma (disorder)
adolescent
Respiratory corticosteroid (substance)
adrenergic beta-2 receptor agonists
guidelines for drug use
Omalizumab
asthma

---
https://www.has-sante.fr/jcms/p_3498562/fr/adtralza-tralokinumab-dermatite-atopique-chez-l-adulte-et-l-adolescent-a-partir-de-12-ans
2024
false
false
false
France
tralokinumab
injections, subcutaneous
adolescent
adult
dermatitis, atopic
Adult atopic dermatitis (disorder)
evaluation of the transparency committee
tralokinumab

---
https://www.has-sante.fr/jcms/p_3498741/fr/takhzyro-lanadelumab-angiooedeme-hereditaire
2024
false
false
false
France
antibodies, monoclonal, humanized
treatment outcome
insurance, health, reimbursement
angioedemas, hereditary
child
lanadelumab
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)
Hereditary angioedema attack
evaluation of the transparency committee
lanadelumab

---
https://www.has-sante.fr/jcms/p_3498915/fr/recommandations-vaccinales-contre-le-zona-place-du-vaccin-shingrix
2024
France
public health guidelines
health planning guidelines
herpes zoster vaccine
herpes zoster, nos
vaccine, nos
Placement
Recommendation
Zoster Vaccine Recombinant, Adjuvanted
Shingles, CTCAE
herpes zoster
Vaccine Therapy
vaccination
Herpes Zoster
preventive immunization/medication

---
https://www.cochrane.org/fr/CD003962/RENAL_traitement-non-immunosuppresseur-dans-la-nephropathie-immunoglobulines
2024
United Kingdom
review of literature
french abstract
Nephropathy
Raw
IgA
kidney diseases
A^y/a
Immunoglobulin Therapy
immunoglobulin, nos
kidney disease, nos
immunosuppressive agents
Immunosuppressant
Intravenous Immunoglobulin Therapy
immunoglobulin A

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-initier-un-test-immunochimique-de-recherche-de-sang-occulte-dans-les-selles-ou-une-coloscopie-a-des-fins-de-depistage-ou-de-diagnostic-du-cancer-colorectal.html
2024
Canada
public health guidelines
Test Name
immunochemistry
colonoscopy
On Study
screening for cancer
dermatomyositis
Colorectal Cancer
Cancer Diagnosis
biomedical research
Laboratory Procedure
Screening Colonoscopy
Test Dosing Unit
Screening for Colorectal Cancer
cancer screening
malignant neoplasm colon/rectum
early detection of cancer
Initiation
diagnosis
no diagnosis
Fecal Occult Blood Test
Blood Products Laboratory Testing
feces
screening for occult blood in feces
Clinical Study Protocol
medical research
colorectal neoplasms
occult blood

---
https://www.inrs.fr/media.html?refINRS=TF%20313
2024
France
journal article
Prevention Study
hypersensitivity reaction, nos
Have Allergy
Preventive Intervention
Implementation
Allergic Reaction
insect, nos
Insecta
animal husbandry
Prevention
hypersensitivity
Insect

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-mars-2024-4-7-mars
2024
false
false
false
France
French
drug information
mRNA Vaccines
COVID-19 Vaccines
Postmenopausal bleeding (finding)
pharmacovigilance

---
https://www.ema.europa.eu/en/medicines/human/EPAR/ebglyss
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
lebrikizumab
lebrikizumab
lebrikizumab
drug approval
europe
dermatitis, atopic
adult
child
adolescent
injections, subcutaneous
risk management
product surveillance, postmarketing
aged
pregnancy
breast feeding
drug interactions
Interleukin-13
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3500011/fr/bimzelx-bimekizumab-psoriasis-en-plaques
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
injections, subcutaneous
bimekizumab
evaluation of the transparency committee
psoriasis
bimekizumab

---
https://www.cochrane.org/fr/CD003216/WOUNDS_quels-sont-les-regimes-ou-les-complements-les-plus-efficaces-pour-prevenir-et-traiter-les-escarres
2024
United Kingdom
review of literature
french abstract
Treatment Regimen
pressure ulcer
complement system proteins
Basal Diet
Ethyl Glucuronide And Ethyl Sulfate Measurement
diet, nos
Treatment Factor
GDC Regimen Terminology
What Month is it
attentiveness
Dietary Supplement
Special Diet Therapy
eschar

---
https://www.has-sante.fr/jcms/p_3501621/fr/nuvaxovid-proteine-spike-de-sars-cov-2-et-un-adjuvant-matrix-m-covid-19
2024
false
false
false
France
vaccine potency
vaccination
COVID-19
COVID-19 Vaccines
insurance, health, reimbursement
adolescent
adult
injections, intramuscular
Adjuvants, Vaccine
Matrix-M
evaluation of the transparency committee
SARS-CoV-2
spike protein, SARS-CoV-2

---
https://www.has-sante.fr/jcms/p_3501630/fr/tepkinly-epcoritamab-lymphome-diffus-a-grande-cellule-b-ldgcb
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
epcoritamab
injections, subcutaneous
Antineoplastic Agents, Immunological
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
adult
Third-Line Therapy
evaluation of the transparency committee
lymphoma, large B-Cell, diffuse
Epcoritamab

---
https://ansm.sante.fr/informations-de-securite/paxlovid-nirmatrelvir-ritonavir-rappel-des-interactions-medicamenteuses-avec-certains-immunosuppresseurs-notamment-le-tacrolimus-pouvant-etre-fatales
2024
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
drug interactions
nirmatrelvir and ritonavir drug combination
nirmatrelvir
immunosuppressive agents
tacrolimus
COVID-19 Drug Treatment
adult
nirmatrelvir and ritonavir
tacrolimus

---
https://ansm.sante.fr/actualites/decision-du-21-03-2024-cadre-de-prescription-compassionnelle-de-tacrolimus-0-1-pommade
2024
false
false
false
France
French
drug information
tacrolimus
administration, cutaneous
ointments
legislation, pharmacy
adult
child
adolescent
vitiligo
tacrolimus

---
https://ansm.sante.fr/tableau-acces-derogatoire/tacrolimus#
2024
false
false
false
France
French
tacrolimus
drug information
administration, cutaneous
vitiligo

---
https://www.has-sante.fr/jcms/p_3503249/fr/elrexfio-elranatamab-myelome-multiple
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antibodies, monoclonal
adult
multiple myeloma
package leaflet
summary of product characteristics
guidelines for drug use
recurrence
Triple-Class Refractory Multiple Myeloma
Recurrent Multiple Myeloma
Progressive Neoplastic Disease
relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and have demonstrated disease progression on the last therapy
elranatamab
evaluation of the transparency committee
Elranatamab

---
https://papyrus.bib.umontreal.ca/xmlui/handle/1866/32798
2024
Canada
dissertations, academic
attention
monoclonal antibody
Monoclonal Antibody
Apply
immunotherapy
immunotherapy, nos
Applicator
antibodies, monoclonal
Immunotherapy
Monoclonal Antibody (Therapeutic)
Apply

---
https://www.has-sante.fr/jcms/p_3505636/fr/rybrevant-amivantamab-cancer-bronchique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
carboplatin
amivantamab
Antineoplastic Agents, Immunological
bispecific monoclonal antibodies
advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
Activating EGFR Exon 20 Mutation
EGFR Exon 20 Insertion Mutation
Pemetrexed
adult
package leaflet
summary of product characteristics
guidelines for drug use
infusions, intravenous
evaluation of the transparency committee
bronchial neoplasms
amivantamab

---
https://www.has-sante.fr/jcms/p_3503160/fr/zilbrysq-zilucoplan-sodique-myasthenie
2024
false
false
false
France
zilucoplan
treatment outcome
insurance, health, reimbursement
myasthenia gravis, generalized
myasthenia gravis
adult
Anti-acetylcholine receptor antibody positivity
evaluation of the transparency committee
zilucoplan
myasthenia gravis

---
https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
risk management
BELATACEPT
immunosuppressive agents
infusions, intravenous
belatacept
patient education handout
Infusion-Related Reaction
infusions, intravenous

---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout

---
https://ansm.sante.fr/tableau-acces-derogatoire/blenrep
2024
false
false
false
France
French
infusions, intravenous
drug information
antibodies, monoclonal, humanized
belantamab mafodotin
Antineoplastic Agents, Immunological

---
https://www.ema.europa.eu/en/medicines/human/EPAR/elrexfio
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
europe
drug approval
Elranatamab
Elranatamab
multiple myeloma
recurrence
Progressive Neoplastic Disease
Triple-Class Refractory Multiple Myeloma
adult
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
Recurrent Multiple Myeloma
antibodies, monoclonal
antibodies, monoclonal
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
injections, subcutaneous
bispecific monoclonal antibodies
bispecific monoclonal antibodies
Immune Effector Cell Associated Neurotoxicity Syndrome
Elranatamab
Cytokine Release Syndrome
continuity of patient care
relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and have demonstrated disease progression on the last therapy
elranatamab

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/equivalence-du-seuil-de-positivite-des-tests-immunochimiques-de-recherche-de-sang-occulte-dans-les-selles-pour-le-depistage-du-cancer-colorectal.html
2024
Canada
review of literature
feces
early detection of cancer
Equivalent
screening for occult blood in feces
cancer screening
screening for cancer
Research
Search
research
immunochemistry
Blood in Stool
colorectal neoplasms
Occult Blood Measurement
Colorectal Cancer
Screening for Colorectal Cancer
occult blood
Liquid Tumor
malignant neoplasm colon/rectum

---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child

---
https://ansm.sante.fr/actualites/modification-des-conditions-de-prescription-et-de-delivrance-de-certaines-biotherapies-utilisees-dans-le-traitement-de-maladies-inflammatoires-chroniques
2024
false
false
false
France
French
guidelines for drug use
injections, subcutaneous
Interleukin Inhibitors
immunosuppressive agents
biological therapy
general practice
antibodies, monoclonal
immunoconjugates
Tumor Necrosis Factor Inhibitors
Chronic inflammatory disorder (disorder)

---
https://ansm.sante.fr/actualites/point-de-situation-des-approvisionnements-en-auto-injecteurs-dadrenaline
2024
false
false
false
France
French
drug information
epinephrine
france
Epinephrine autoinjector (physical object)

---
https://ansm.sante.fr/tableau-marr/eculizumab-1
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
Drug-Related side effects and adverse reactions
vaccination
patients guideline
Infections
sepsis
meningococcal infections
risk

---
https://publications.msss.gouv.qc.ca/msss/document-002057/
2024
false
false
false
Canada
patient education handout
leaves, nos
Person Info
vaccination
preventive immunization/medication
vaccine, nos
vaccination, nos
persons
Vaccination
toilet facilities
vaccinia
Vaccinated
Vaccine
vaccination
vaccinia, nos
Personal Information
Leaf
vaccines

---
https://www.has-sante.fr/jcms/p_3443053/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2024
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
Unresectable HER2-Positive Breast Carcinoma
Metastatic HER2-Positive Breast Carcinoma
neoplasm metastasis
trastuzumab deruxtecan
guidelines for drug use
Antineoplastic Agents, Immunological
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
trastuzumab deruxtecan
Trastuzumab

---
https://ansm.sante.fr/tableau-acces-derogatoire/mabthera-100-mg-solution-a-diluer-pour-perfusion
2024
false
false
false
France
French
infusions, intravenous
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug)
Rituximab
drug information
guidelines for drug use
Refractory immune thrombocytopenic purpura
purpura, thrombocytopenic, idiopathic
immunologic factors
technical report

---
https://ansm.sante.fr/actualites/nulojix-belatacept-pour-la-greffe-de-rein-recommandations-temporaires-pour-garantir-la-continuite-des-soins
2024
false
false
false
France
French
guidelines for drug use
Abatacept

---
https://ansm.sante.fr/tableau-acces-derogatoire/sotrovimab-500-mg-solution-a-diluer-pour-perfusion-intraveineuse-xevudy
2024
false
false
false
France
French
infusions, intravenous
drug information
adult
adolescent
COVID-19
sotrovimab
sotrovimab

---
https://www.has-sante.fr/jcms/p_3418585/fr/yescarta-axicabtagene-ciloleucel-lymphome-ldgcb-lhgcb
2024
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
insurance, health, reimbursement
treatment outcome
Recurrent High Grade B-Cell Lymphoma
lymphoma, large B-Cell, diffuse
Refractory High Grade B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
adult
infusions, intravenous
gene therapy
axicabtagene ciloleucel

---
https://www.has-sante.fr/jcms/p_3423139/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2024
false
false
false
France
Generalized pustular psoriasis
spesolimab
adult
treatment outcome
insurance, health, reimbursement
infusions, intravenous
evaluation of the transparency committee
psoriasis
spesolimab

---
https://ansm.sante.fr/tableau-marr/rituximab-3
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Rituximab
Rituximab
risk management
continuity of patient care
child
infusions, intravenous
leukoencephalopathy, progressive multifocal
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-acces-derogatoire/berinert-500-ui-mg-poudre-et-solvant-pour-solution-injectable-perfusion
2024
false
false
false
France
French
complement C1 inhibitor protein
guidelines for drug use
continuity of patient care
salvage therapy
graft rejection
Humoral rejection
heart transplantation
kidney transplantation
lung transplantation
infusions, intravenous
complement C1 inhibitor protein
technical report

---
https://ansm.sante.fr/tableau-marr/teclistamab
2024
false
false
false
France
French
popular works
drug information
Teclistamab
risk management
teclistamab

---
https://ansm.sante.fr/tableau-acces-derogatoire/adcetris-50-mg-poudre-pour-solution-a-diluer-pour-perfusion
2024
false
false
false
France
French
continuity of patient care
guideline
hodgkin disease
child
adolescent
adult
antineoplastic combined chemotherapy protocols
brentuximab vedotin
Brentuximab Vedotin
infusions, intravenous

---
https://ansm.sante.fr/tableau-marr/axicabtagene-ciloleucel
2024
false
false
false
France
French
risk management
axicabtagene ciloleucel
guidelines for drug use
axicabtagene ciloleucel
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
nervous system diseases
patient education handout
signs and symptoms
axicabtagene ciloleucel
infusions, intravenous
gene therapy

---
https://ansm.sante.fr/tableau-marr/panobinostat
2024
false
false
false
France
French
risk management
Panobinostat
panobinostat
administration, oral
medication errors
patients guideline
patient compliance

---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents

---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection

---
https://ansm.sante.fr/tableau-acces-derogatoire/vyvgart
2024
false
false
false
France
French
efgartigimod alfa
infusions, intravenous
myasthenia gravis, generalized
Acetylcholine receptor antibody (substance)
Anti-acetylcholine receptor antibody positivity
efgartigimod alfa
generalised myasthenia gravis with anti-acetylcholine receptor antibody
drug information

---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/ponesimod
2024
false
false
false
France
French
risk management
ponesimod
ponesimod
administration, oral
ponesimod
ponvory
guidelines for drug use
patients guideline
pregnancy
continuity of patient care
ponesimod
adult
multiple sclerosis, relapsing-remitting
drug monitoring
immunosuppressive agents
immunosuppressive agents
immunosuppressive agents

---
https://ansm.sante.fr/tableau-marr/eculizumab
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout
Drug-Related side effects and adverse reactions
meningococcal vaccines

---
https://www.who.int/fr/publications-detail/9789240092822
2024
Switzerland
technical report
preventive immunization/medication
Biological Agent
senegalese
vaccination, nos
Location of Pharyngeal Residue Following Swallowing
vaccinia, nos
Vaccine Production
Locally
Case Study
Anatomic Site
Local-Regional
vaccines
senegal
snacks
vaccination
Case Series
Location of Oral Residue Following Swallowing
GDC Therapeutic Agent Terminology
biological products
economics
drug, nos
biology
vaccine, nos
ecosystem
data collection
Application Context
production
pharmaceutical preparations
case study
Localized Disease

---
https://www.has-sante.fr/jcms/p_3517160/fr/tecentriq-atezolizumab-oncologie
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only atezolizumab in parenteral dose form (medicinal product form)
atezolizumab
antineoplastic combined chemotherapy protocols
Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel Regimen
neoplasm metastasis
carcinoma, non-small-cell lung
small cell lung carcinoma
Extensive Stage Lung Small Cell Carcinoma
antineoplastic agents
Unresectable Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
carcinoma, hepatocellular
evaluation of the transparency committee
atezolizumab

---
https://www.has-sante.fr/jcms/p_3517560/fr/soliris-eculizumab-myasthenie
2024
false
false
false
France
eculizumab
generalised myasthenia gravis with anti-acetylcholine receptor antibody
treatment outcome
child
Acetylcholine receptor antibody (substance)
infusions, intravenous
evaluation of the transparency committee
eculizumab
myasthenia gravis

---
https://www.has-sante.fr/jcms/p_3517411/fr/elrexfio-elranatamab-myelome-multiple
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and have demonstrated disease progression on the last therapy
Recurrent Multiple Myeloma
antibodies, monoclonal
Triple-Class Refractory Multiple Myeloma
adult
injections, subcutaneous
Progressive Neoplastic Disease
recurrence
elranatamab
evaluation of the transparency committee
multiple myeloma
Elranatamab

---
https://minerva-ebp.be/FR/Analysis/868
2024
Belgium
critical appraisal or critical reading
opioids
Methadone Measurement
patients
methadone
mindfulness
consciousness, nos
Line of Therapy
complement system proteins
Cloud Computing
What Month is it
Disease or Disorder
Radiation Boost
has patient
opiate agonist, nos
methadone
analgesics, opioid
Consciousness
Patient
Methadone
Awareness

---
https://www.has-sante.fr/jcms/p_3518649/fr/ilaris-canakinumab-crise-d-arthrite-goutteuse
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Acute gout (disorder)
canakinumab
injections, subcutaneous
evaluation of the transparency committee
canakinumab
arthritis, gouty

---
https://www.academie-medecine.fr/wp-content/uploads/2024/05/Projet-Vaccination_Lycee-Lucie-Aubrac-Pantin.pdf
2024
France
scientific and technical information
vaccination, nos
vaccinia, nos
vaccination
vaccines
Vaccine
vaccine, nos
preventive immunization/medication

---
https://www.rheuma-net.ch/fr/doc/cyclophosphamid-1/viewdocument/348
2024
Switzerland
guideline
cyclophosphamide
cyclophosphamide
Background Treatment
Cyclophosphamide

---
https://kce.fgov.be/fr/publications/tous-les-rapports/utilisation-des-marquages-immunohistochimiques-et-de-la-microscopie-electronique-en-belgique
2024
Belgium
technical report
french abstract
Electron Microscopy
belgium
Use
microscopy, electron
Immunohistochemistry Staining Method
Belgium
immunohistochemistry
electron microscopic study, nos

---
https://www.has-sante.fr/jcms/p_3519011/fr/xolair-omalizumab-asthme-allergique-urticaire-chronique-spontanee
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
asthma
Allergic asthma (disorder)
injections, subcutaneous
anti-asthmatic agents
anti-allergic agents
evaluation of the transparency committee
Omalizumab
Chronic Spontaneous Urticaria
Chronic Urticaria

---
https://www.youtube.com/playlist?list=PLtIOHxI9gZvnBkvv7A1JTvZcn8iZUAdl7
2024
France
popular works
video recording
nicotiana tabacum
Nicotiana
neoplasm, malignant
hypersensitivity
Tobacco Smoking
Sensitization
cancer
neoplasms
Malignant Neoplasm
Smoking Tobacco

---
https://www.inspq.qc.ca/publications/3495
2024
Canada
public health guidelines
vaccinia virus
aged
quebec
Schedule
vaccination
preventive immunization/medication
age under 20 years
Karnofsky Performance Status 20
viral vaccines
elderly person, nos
Calendar
Human Papillomavirus
immunization schedule
Human Papillomavirus Viruses
aged, 80 and over
Autonomic Nervous System
Schedule
papillomaviridae
human papillomavirus, nos
Vaccinia Virus
Elderly
Lansky Performance Status 20
Twenty
personhood
Andorra
vaccinia virus

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pyzchiva
2024
false
false
false
Netherlands
French
English
Ustekinumab
Ustekinumab
drug approval
europe
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
biosimilar pharmaceuticals
ustekinumab
psoriasis
arthritis, psoriatic
drug interactions
pregnancy
breast feeding
crohn disease
colitis, ulcerative
Product containing only ustekinumab in parenteral dose form (medicinal product form)
infusions, intravenous
Interleukin Inhibitors
Interleukin Inhibitors
Interleukin-12
Interleukin-23
injections, subcutaneous

---
https://www.ema.europa.eu/en/medicines/human/EPAR/uzpruvo
2024
false
false
false
Netherlands
French
English
drug approval
europe
Ustekinumab
Ustekinumab
syndication feed
summary of product characteristics
package leaflet
drug evaluation
biosimilar pharmaceuticals

---
https://publications.msss.gouv.qc.ca/msss/document-003751/
2024
Canada
patient education handout
vaccination
vaccinia
vaccines
vaccinia virus vaccine
vaccination
Vaccine Therapy
Privacy
Vaccine
preventive immunization/medication
Vaccination

---
https://www.has-sante.fr/jcms/p_3522389/fr/ebglyss-lebrikizumab-dermatite-atopique
2024
false
false
false
France
lebrikizumab
treatment outcome
insurance, health, reimbursement
adult
antibodies, monoclonal
evaluation of the transparency committee
lebrikizumab
dermatitis, atopic

---
https://ansm.sante.fr/actualites/decision-du-19-06-2024-fixant-en-application-du-iii-de-larticle-r-5124-49-4-du-csp-le-seuil-du-stock-de-securite-destine-au-marche-national-pour-des-mitm-du-laboratoire-grifols
2024
false
false
false
France
French
legislation
drug information
immunoglobulins, intravenous

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/vaccins/zostavax-poudre-et-solvant-pour-suspension-injectable-en-seringue-preremplie-vaccin-zona-vivant-attenue
2024
false
false
false
France
French
drug information
zoster, live attenuated
herpes zoster
herpes zoster vaccine

---
https://ansm.sante.fr/actualites/a-compter-du-10-07-2024-la-cyproheptadine-periactine-4mg-sera-dispensee-uniquement-sur-ordonnance
2024
false
false
false
France
French
drug information
cyproheptadine
cyproheptadine
prescription drugs
Off-Label use

---
https://www.has-sante.fr/jcms/p_3526096/fr/vaxchora-vaccin-contre-le-cholera-vivant-recombine-oral-vaccin-anticholerique
2024
false
false
false
France
cholera
vaccination
administration, oral
insurance, health, reimbursement
cholera, live attenuated
adult
child
adolescent
mayotte
evaluation of the transparency committee
vaccines, recombinant
cholera vaccines
vaccines, synthetic
vaccination

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_n2024_10.pdf
2024
France
public health guidelines
seasons
Infection
Infections
infant, newborn
infectious disease, nos
Verbal Rating Scale
vaccination, nos
New Lesion Identification
Season
Newar Language
NES Gene
respiratory syncytial virus infections
Chuvash Language
immunization
newborn, nos
Vienna Rectoscopy Score
Immunization
infant
Deimmunization

---
https://ansm.sante.fr/tableau-marr/adrenaline-1
2024
false
false
false
France
French
epinephrine
risk management
guidelines for drug use
patients guideline
emergency treatment
Epinephrine autoinjector (physical object)
injections, intramuscular
self administration
video recording

---
https://www.cochrane.org/fr/CD015060/RENAL_therapie-immunosuppressive-pour-le-traitement-de-la-maladie-de-berger-chez-lenfant
2024
United Kingdom
review of literature
french abstract
child, nos
Child Relation
primary iga nephropathy
IgA Nephropathy
Immunosuppressive Therapy
Child Individual
disease
glomerulonephritis, iga
GDC Treatment or Therapy Terminology
child
Immunosuppression Therapy
immunosuppressive therapy, nos

---
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/Tableau%20complet%20vaccinations%20-%20MeP%20DEF.pdf
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/Fiche%20synth%C3%A8se%20vaccinations%20-%20MeP%20DEF.pdf
2024
France
scientific and technical information
Vaccine
AICDA wt Allele
vaccination
vaccine, nos
Acute Interstitial Pneumonia
Tables
renal insufficiency, chronic
Assistance
Vaccinated
kidney diseases
Single-Stranded DNA Cytosine Deaminase
kidney disease, nos
Prescription
With Some Help
Chronic Kidney Disease, CTCAE
Without Help
chronic disease
Atherogenic Index of Plasma
chronic disease, nos
Table
vaccinia
preventive immunization/medication
AH Receptor-Interacting Protein
vaccination
vaccines
Vaccination
prescription, nos
vaccination, nos
AIP Gene
Chronic Renal Failure
vaccinia, nos

---
https://www.has-sante.fr/jcms/p_3530407/fr/cyclophosphamide-accord-cyclophosphamide-cancer-et-maladies-auto-immunes
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only cyclophosphamide in parenteral dose form (medicinal product form)
precursor cell lymphoblastic Leukemia-Lymphoma
cyclophosphamide
transplantation conditioning
multiple myeloma
hodgkin disease
lymphoma, Non-Hodgkin
ovarian neoplasms
breast neoplasms
neoplasm metastasis
sarcoma, ewing
small cell lung carcinoma
bronchial neoplasms
neuroblastoma
lupus nephritis
Granulomatosis with Polyangiitis
myeloablative agonists
antineoplastic agents, alkylating
immunosuppressive agents
evaluation of the transparency committee
cyclophosphamide
autoimmune diseases

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/traitement-intravesical-du-cancer-de-la-vessie.html
2024
Canada
technical report
review of literature
guideline
weights and measures
musculoskeletal rotation, nos
Preventive
Bacillus Calmette-Guerin Antigen
measures
Childhood Bladder Carcinoma
patients
preventive treatment, nos
Epidermolytic Ichthyosis
Patient Reported Outcome Measures
has patient
malignant neoplasm of bladder
BCG
KRT10 wt Allele
Cancer Therapeutic Procedure
BCG
Intravesical
Intravesical Route of Administration
rotation
BCG Vaccine
BCG
urinary bladder cavity
People
urinary bladder cancer
neoplasm, malignant
mycobacterium bovis
persons
Clinical Outcomes Assessment Context of Use
Patient
immunocompromised host
urinary bladder neoplasms
Bladder Cancer Pathway

---
https://www.ce-mir.fr/files/medias/documents/23.%20Exacerbation%20s%C3%A9v%C3%A8re%20d%27asthme.pdf
2024
France
educational course
asthma, nos
Severe Adverse Event
Severe Hallucination
Asthma Pathway
asthma
Borg Category-Ratio 10 Perceived Exertion Score 5
Asthma
Intensity and Distress 5
Severe Extremity Pain
severe
Severe Dysplasia
Epidermal cGVHD Score 4
asthma
Exacerbation

---
https://www.ce-mir.fr/files/medias/documents/44.%20Fi%C3%A8vre%20chez%20l%27immunod%C3%A9prim%C3%A9.pdf
2024
France
educational course
fever
Fractional Excretion of Potassium
increased body temperature
Fever, CTCAE
LGR5 wt Allele
Fever
Breast Flat Ductal Epithelial Atypia
METTL13 wt Allele
Have Fever
Immunocompromised
fever
immunocompromised host

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/asthme
2024
France
educational course
asthma
asthma, nos
asthma
Asthma Pathway
Asthma

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/hypersensibilites-allergies
2024
France
educational course
hypersensitivity reaction, nos
hypersensitivity
Have Allergy
Allergic Reaction

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/infectiologie/vaccinations
2024
France
educational course
vaccination
vaccine, nos
vaccinia
Vaccine
Vaccinated
Vaccination
vaccination
preventive immunization/medication
vaccinia, nos
vaccines
vaccination, nos

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/hematologie-cancerologie/deficits-immunitaires-hereditaires
2024
France
educational course
immunologic deficiency syndromes
Inherited
Immunodeficiency

---
https://www.has-sante.fr/jcms/p_3530992/fr/enhertu-trastuzumab-deruxtecan-cancer-du-poumon
2024
false
false
false
France
evaluation of the transparency committee
Lung Carcinoma
neoplasm, malignant
Trastuzumab Deruxtecan
lung neoplasms
Trastuzumab Deruxtecan
trastuzumab deruxtecan
lung cancer
trastuzumab
Trastuzumab
trastuzumab deruxtecan

---
https://www.has-sante.fr/jcms/p_3530995/fr/simulect-basiliximab-prevention-du-rejet-de-greffe-renale
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
transplantation, homologous
adult
adolescent
child
infant
Product containing precisely basiliximab 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely basiliximab 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)
immunosuppressive agents
basiliximab
evaluation of the transparency committee
graft rejection
kidney transplantation
Basiliximab

---
https://iris.who.int/handle/10665/378270
2024
Switzerland
journal article
advisory committees
Implementation
February
Nicotine Lozenge
mars
vaccination
March
preventive immunization/medication
research
Vaccination
vaccinia virus vaccine
vaccines
Reunion
Vaccine Research
Meeting
group processes
vaccination
Consultation

---
https://ansm.sante.fr/tableau-marr/vaccin-contre-le-cholera-vivant-recombine-oral
2024
false
false
false
France
French
cholera vaccines
risk management
administration, oral
cholera
cholera, live attenuated
patients guideline
guidelines for drug use
medication errors

---
https://ansm.sante.fr/informations-de-securite/abecma-breyanzi-carvykti-kymriah-tecartus-et-yescarta-therapies-cellulaires-car-t-dirigees-contre-les-antigenes-cd19-ou-bcma-risque-de-tumeur-maligne-secondaire-issue-de-lymphocytes-t
2024
false
false
false
France
French
pharmacovigilance note
Secondary Malignant Neoplasm
Anti-CD19 CAR T Cells Preparation
Anti-BCMA CAR T Cells Preparation
Chimeric Antigen Receptor Therapy
lymphoma, T-Cell
continuity of patient care
hematologic neoplasms
leukemia, t-cell
Antineoplastic cell and gene therapy

---
https://ansm.sante.fr/informations-de-securite/acetate-de-glatiramere-des-reactions-anaphylactiques-peuvent-survenir-des-mois-voire-des-annees-apres-linstauration-du-traitement
2024
false
false
false
France
French
pharmacovigilance note
Glatiramer Acetate
glatiramer acetate
adjuvants, immunologic
anaphylaxis
Anaphylactic Reaction
injections, subcutaneous
multiple sclerosis, relapsing-remitting

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/vaccins/revaxis-suspension-injectable-en-seringue-preremplie-vaccin-diphterique-tetanique-et-poliomyelitique-inactive-adsorbe-a-teneur-reduite-en-antigenes-anatoxine-diphterique-anatoxine-tetanique-virus-poliomyelitique-inactive
2024
false
false
false
France
French
diphtheria-tetanus vaccine
poliovirus vaccine, inactivated
drug information
immunization, secondary

---
https://publications.msss.gouv.qc.ca/msss/document-003773/
2024
Canada
scientific and technical information
Schedule
Chuvash Language
respiratory syncytial virus infection, nos
Responsive Disease
Program
immunization
Vienna Rectoscopy Score
Questioning
intention
respiratory syncytial virus infections
Response_Gloss
Pet Responds to Presence
immunization programs
health
Scheduled
Respiratory Syncytial Virus Infection
vaccination, nos
Examination Questions
Verbal Rating Scale
Immunization
health personnel
Deimmunization
Health Professional

---
https://www.has-sante.fr/jcms/p_3534136/fr/menquadfi-vaccin-meningococcique-des-groupes-a-c-w-135-et-y-conjugue-a-l-anatoxine-tetanique-vaccin-anti-meningococcique
2024
false
false
false
France
insurance, health, reimbursement
vaccine potency
vaccination
meningococcal infections
child
infant
immunization, secondary
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
public health guidelines
adolescent
evaluation of the transparency committee
meningococcal vaccines

---
https://www.has-sante.fr/jcms/p_3536075/fr/vyvgart-efgartigimod-alfa-myasthenie-auto-immune-generalisee
2024
false
false
false
France
generalised myasthenia gravis with anti-acetylcholine receptor antibody
myasthenia gravis
myasthenia gravis, generalized
insurance, health, reimbursement
treatment outcome
adult
efgartigimod alfa
evaluation of the transparency committee
efgartigimod alfa

---
https://www.has-sante.fr/jcms/p_3535401/fr/abrysvo-vaccin-du-virus-respiratoire-syncytial-bivalent-recombinant-virus-respiratoire-syncytial-vrs-chez-les-nourrissons
2024
false
false
false
France
infant, newborn
pregnancy
Pregnant People
immunization, passive
respiratory syncytial virus infections
vaccination
Recommendation regarding vaccination (procedure)
respiratory syncytial virus vaccines
evaluation of the transparency committee
Bivalent Vaccines
vaccination
infant
reassortant viruses
respiratory syncytial virus vaccines

---
https://www.has-sante.fr/jcms/p_3534142/fr/bexsero-vaccin-meningococcique-groupe-b-adnr-composant-adsorbe-vaccin-anti-meningococcique-serogroupe-b
2024
false
false
false
France
insurance, health, reimbursement
vaccine potency
vaccination
meningococcus B, multicomponent vaccine
injections, intramuscular
infant
child
meningococcal infections
Invasive meningococcal disease (disorder)
Meningococcal Group B Vaccine
neisseria meningitidis, serogroup B
evaluation of the transparency committee
meningococcal vaccines
vaccination

---
Nous contacter.
23/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.